ILSI-Biomed Israel

ILSI-BioMed 2010 Has Begun!

This morning the ILSI-BioMed Week 2010 has finally been launched, with 7,000 anticipated participants that will take part in lectures and meetings with the experts and seniors of the bio-pharma and medical equipment industry in Israel and abroad. Following the opening words of the event's organizers, ILSI and Kenes, the president of Israel Shimon Peres came up to the stage and surveyed the future of Israel, which will be based on advanced technologies and serve as an example to the entire...

A French Delegation in the Negev

A French delegation has visited today (Sunday, 13.6.2010) at Ben-Gurion University, as the guest of Bio-Negev, the international center for innovation in the biotechnology industry and life sciences in the Negev. The purpose of the visit is to examine potential collaboration between the visitors and the new initiative in the Negev, BGU being one of the partners in the project. Prof. Rivka Carmi, president of the university, places a great amount of value in the initiative, which can be direct...

BioMed 2010 week Innovations: The New Generation of PainShield

NanoVibronix will present the second generation of PainShield – for the treatment of pain and chronic wounds using ultrasound waves Following the commercial success of the first generation PainShield device, for the treatment of (surprise, surprise) pain, especially one that stems from Trigeminal Neualgia, the Israeli company NanoVibronix now reveals the second generation of the device. This time, it has some extra capabilities to treat chronic wounds. NanoVibronix, based in Nesher, is develo...

Israel’s Life Sciences Export On the Rise

The Coming ILSI–Biomed Israel 2010 Week: The Israel Export and International Cooperation Institute: Life Sciences Export Rose by 14% on the First Quarter of 2010, Summing up to the Total of ca. $1.7 Billion “The first 2010 quarter export of the life sciences industry summed up to ca. $1.7 billion, an increase of about 14 percent compared to the same period last year. This increase is derived from a 15.4 percent increase in the export of medications, which has summed up to ca. $1.3 Billion...

Stem Cells as Seek-and-Destory Missiles against Cancer

As published in New Scientist, stem cells were succesfully modified to act as seek-and-destroy missiles against cancer in mice brains Stem cells are often viewed as the ultimate solution for regenerative medicine, and for a good cause. Given the correct cues, they can regenerate whole parts of the body, and even re-create an entire embryo (although that would require QUITE some understanding of the cues involved in the process). It seems, however, that now a new use has been found for the...

Researchers from RAMBAM Hospital Fight Parkinson’s Disease with Imagination

A new research from RAMBAM hospital shows that Guided Affective Imagery (דמיון מודרך) can make the tremors of Parkinson's disease go away. The relationship between the mind and the body has never been fully determined. Worse, the field is wide open for charlatans, holistic healers, homeopaths, naturopaths and what-have-you. However, from time to time we get some ‘real’ peer-reviewed scientific papers that offer new insights on the mind-body link. Such a paper was recently published in the...

Cardiovascular Therapy in the 2020s

As part of the BioMed Conference, a Cardiovascular Technology Workshop will be held on Monday, June 14, 12:00–18:30 at the Dan Panorama Hotel, Tel Aviv This message is also available online   Cardiovascular Therapy in the 2020s An ILSI-BioMed Workshop Sponsored by As part of the BioMed Conference, a Cardiovascular Technology Workshop will be held on Monday, June 14, 12:00–18:30 at the Dan Panorama Hotel, Tel Aviv.The most acclaimed inte...

Startup Weekly: ProtAb – Antibodies Against Arthritis

ProtAb is a company dedicated to eveloping an antibody for the treatment of Rheumatoid Arthritis and other autoimmune diseases such as Crohn's Disease, and has recently raised $4 million. Name: ProtAb CEO: Shira Yair Sector: Biopharma Medical Field: Autoimmune Diseases Est.: 2005 Stage: Late stage pre-clinical, after series A funding Vision: To develop a novel therapeutics for autoimmune diseases, based on the induction of natural anti-inflammatory mechanisms existing in...

Networking with Five Italian Companies

Five Italian biomedical companies are coming to Israel, and are interested in meeting suitable Israeli business partners It’s not WHAT you know, it’s WHO you know! Relationships are the catalyst for success! Do the above two statements look familiar? They should. They are the axioms of the Networking Theory (name not trademarked, invented on the spot). While networking seems to be the new religion of the business folks, I daresay that it’s been around for quite a bit. Even apes have...

A Novel Artificial Pancreas System

An aritifical pancreas system that maintains near-normal glucose levels by injecting both insulin and glucagon was succesfully demonstrated on a small number of patients An artificial pancreas system that closely mimics the body's blood sugar control mechanism was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of patients. The system, combining a blood glucose monitor and insulin pump technology with software that directs administration of insulin an...